The untreated A375 secretome is rich in TGF-alpha, IL-8, and MFG-E8 while the injured A375 secretome is rich in CCL2 and S100B, indicative of a shift in molecular cues supporting tumor progression to molecular cues supporting myeloid cell recruitment (40–43). The gene discussed is S100B; the disease is neoplasm.